These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35343934)

  • 41. DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
    Song Y; Huang J; Liang D; Hu Y; Mao B; Li Q; Sun H; Yang Y; Zhang J; Zhang H; Chen H; Liu H; Zhang S
    Front Oncol; 2020; 10():549777. PubMed ID: 33680909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability.
    Ratovomanana T; Nicolle R; Cohen R; Diehl A; Siret A; Letourneur Q; Buhard O; Perrier A; Guillerm E; Coulet F; Cervera P; Benusiglio P; Labrèche K; Colle R; Collura A; Despras E; Le Rouzic P; Renaud F; Cros J; Alentorn A; Touat M; Ayadi M; Bourgoin P; Prunier C; Tournigand C; Fouchardière C; Tougeron D; Jonchère V; Bennouna J; de Reynies A; Fléjou JF; Svrcek M; André T; Duval A
    Ann Oncol; 2023 Aug; 34(8):703-713. PubMed ID: 37269904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PD-1/PD-L1-dependent immune response in colorectal cancer.
    Payandeh Z; Khalili S; Somi MH; Mard-Soltani M; Baghbanzadeh A; Hajiasgharzadeh K; Samadi N; Baradaran B
    J Cell Physiol; 2020 Jul; 235(7-8):5461-5475. PubMed ID: 31960962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
    Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
    Lin A; Zhang J; Luo P
    Front Immunol; 2020; 11():2039. PubMed ID: 32903444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SLAMF7 and TREM1 Mediate Immunogenic Cell Death in Colorectal Cancer Cells: Focus on Microsatellite Stability.
    Roh SA; Kwon YH; Lee JL; Kim SK; Kim JC
    Anticancer Res; 2021 Nov; 41(11):5431-5444. PubMed ID: 34732412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
    André T; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt C; Smith D; Garcia-Carbonero R; Benavides M; Gibbs P; de la Fouchardiere C; Rivera F; Elez E; Bendell J; Le DT; Yoshino T; Van Cutsem E; Yang P; Farooqui MZH; Marinello P; Diaz LA;
    N Engl J Med; 2020 Dec; 383(23):2207-2218. PubMed ID: 33264544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches.
    Tan E; Sahin IH
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):735-742. PubMed ID: 33539189
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer.
    Thomas J; Leal A; Overman MJ
    Clin Colorectal Cancer; 2020 Jun; 19(2):73-81. PubMed ID: 32173280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal Cancer.
    Gurjao C; Liu D; Hofree M; AlDubayan SH; Wakiro I; Su MJ; Felt K; Gjini E; Brais LK; Rotem A; Rosenthal MH; Rozenblatt-Rosen O; Rodig S; Ng K; Van Allen EM; Corsello SM; Ogino S; Regev A; Nowak JA; Giannakis M
    Cancer Immunol Res; 2019 Aug; 7(8):1230-1236. PubMed ID: 31217164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies
    Pereira C; Gimenez-Xavier P; Pros E; Pajares MJ; Moro M; Gomez A; Navarro A; Condom E; Moran S; Gomez-Lopez G; Graña O; Rubio-Camarillo M; Martinez-Martí A; Yokota J; Carretero J; Galbis JM; Nadal E; Pisano D; Sozzi G; Felip E; Montuenga LM; Roz L; Villanueva A; Sanchez-Cespedes M
    Clin Cancer Res; 2017 Jun; 23(12):3203-3213. PubMed ID: 28302866
    [No Abstract]   [Full Text] [Related]  

  • 52. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.
    Jin HY; Liu X; Li VK; Ding Y; Yang B; Geng J; Lai R; Ding S; Ni M; Zhao R
    BMC Cancer; 2008 Feb; 8():44. PubMed ID: 18257912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.
    Wang X; Fang Y; Liang W; Wong CC; Qin H; Gao Y; Liang M; Song L; Zhang Y; Fan M; Liu C; Lau HC; Xu L; Li X; Song W; Wang J; Wang N; Yang T; Mo M; Zhang X; Fang J; Liao B; Sung JJY; Yu J
    Cancer Cell; 2024 Oct; 42(10):1729-1746.e8. PubMed ID: 39303724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The evolving role of microsatellite instability in colorectal cancer: A review.
    Gelsomino F; Barbolini M; Spallanzani A; Pugliese G; Cascinu S
    Cancer Treat Rev; 2016 Dec; 51():19-26. PubMed ID: 27838401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a
    Gong J; Wang C; Lee PP; Chu P; Fakih M
    J Natl Compr Canc Netw; 2017 Feb; 15(2):142-147. PubMed ID: 28188185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frameshift mutation of a histone methylation-related gene SETD1B and its regional heterogeneity in gastric and colorectal cancers with high microsatellite instability.
    Choi YJ; Oh HR; Choi MR; Gwak M; An CH; Chung YJ; Yoo NJ; Lee SH
    Hum Pathol; 2014 Aug; 45(8):1674-81. PubMed ID: 24925220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors.
    Lin Y; Luo S; Luo M; Lu X; Li Q; Xie M; Huang Y; Liao X; Zhang Y; Li Y; Liang R
    Mol Carcinog; 2023 Sep; 62(9):1271-1283. PubMed ID: 37232365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer.
    Yamamoto Y; Shimada S; Akiyama Y; Tsukihara S; Sugimoto R; Kabashima A; Tokunaga M; Kinugasa Y; Kawakami Y; Tanaka S
    J Gastroenterol; 2023 Jun; 58(6):540-553. PubMed ID: 36859628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.